MVision and OncoMed-Solutions partner in Eastern Europe & Russia

It is always a great pleasure to welcome new partners to our global network! This time, we are happy to announce a partnership with OncoMed-Solutions in Eastern Europe and Russia. Through the agreement, the Swiss-based company assumes responsibility for the distribution of MVision’s segmentation services in the Eastern European territory.

”We have already received great feedback from clinics in Eastern Europe, and it is wonderful that OncoMed-Solutions can now help us make our services even more available in the region”, says Mahmudul Hasan, founder and CEO of MVision. “Our mission is to bring new innovative technologies to the oncology market, we are very excited to work with MVision to set new standards for the quality of radiation therapy treatments to our customers”, continues Achim Schefczik, founder and CEO of OncoMed-Solutions.”.

For more information, please contact pr@mvision.ai.

Our Newsletter

Subscribe to get information, latest news and other interesting offers about MVision AI

Related Posts

20.11.2024

MVision AI Ranked Among the Top 10 in Deloitte Technology Fast 50 Finland for 2024

Helsinki, Finland, 20 November 2024 – MVision AI, a leading innovator in AI-driven solutions for oncology, is proud to announce its recognition among the top ten companies in the Deloitte Technology Fast 50 Finland 2024 ranking. This prestigious award acknowledges MVision AI's rapid growth and its mission-driven advancements in making…

Press Releases

7.11.2024

Safe and Ethical AI in Radiation Oncology: Regulations and MVision’s Compliance

Technology is evolving, and the same applies to Radiation Oncology. New ways and new tools require new rules. Artificial intelligence (AI)  brings tremendous potential, so the world has to learn how to get the best of it, safely.  Al systems identified as high-risk have to comply with strict requirements, including…

Articles

24.10.2024

MVision AI Secures FDA 510(k) Clearance for Contour+ Advanced CT and MR Models

Helsinki, October 2024 – MVision AI, a leading innovator in AI-powered solutions for radiotherapy, is thrilled to announce that its auto-contouring solution Contour+ has received FDA 510(k) clearance for three new models: Bones CT, Brain MR, and Male Pelvis MR T2, and five updated models: Brain CT, Abdomen & Lung…

Press Releases